The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients undergoing either an elective major hip or knee replacement or revision.
Signed written informed consent. Men or women of non-child bearing potential(i.e., post menopausal or with hysterectomy of bilateral tubule ligation) or women of childbearing potential without any plan to have a child.
History of serious active bleeding in last 3 month
Concurrent or history of thrombocytopenia ( Platelet< 100x109/L)
History of hypersensitivity reaction to heparin, Low molecular weight heparin or pork product
Acute bacterial endocarditis
Congenital or acquired bleeding disease in last 3 months
Concurrent uncontrolled ulcer or gastrointestinal disease with blood vessel dysplasia
Concurrent hemorrhagic cerebrovascular disease or surgical history in cerebral, spine or eye
Conditions need to leave a tubule in intradural or extradural
Contraindication to anticoagulant or condition required to take long term oral anticoagulant
Abnormality in hepatic (>1.5x UNL), renal (Clcr < 30ml/min) or cardiac function, uncontrolled hypertension or tumor Concurrent disorder of blood vessel in lower limb
Positive result in Human Chorionic Gonadotropin test Participated in any other investigational study on Deep Vein Thrombosis prevention in last 90 days.
Concurrently to have hip and knee or double hip/knee replacement at the same time